Bausch + Lomb Corporation (BLCO)

NYSE: BLCO · IEX Real-Time Price · USD
16.84
-0.27 (-1.58%)
Feb 28, 2024, 2:33 PM EST - Market open
-1.58%
Market Cap 5.92B
Revenue (ttm) 4.15B
Net Income (ttm) -260.00M
Shares Out 350.99M
EPS (ttm) -0.74
PE Ratio n/a
Forward PE 30.31
Dividend n/a
Ex-Dividend Date n/a
Volume 302,921
Open 16.86
Previous Close 17.11
Day's Range 16.72 - 17.09
52-Week Range 13.62 - 21.95
Beta n/a
Analysts Buy
Price Target 19.78 (+17.46%)
Earnings Date Feb 21, 2024

About BLCO

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products for therapeutic use, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, dry eye, and redness relief. The Op... [Read more]

Sector Healthcare
IPO Date May 6, 2022
Employees 13,300
Stock Exchange NYSE
Ticker Symbol BLCO
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for BLCO stock is "Buy." The 12-month stock price forecast is $19.78, which is an increase of 17.46% from the latest price.

Price Target
$19.78
(17.46% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Bausch & Lomb's stock soars 11% after earnings beat

Bausch + Lomb Corp.'s stock soared 10% early Wednesday, after the vision-care company's adjusted fourth-quarter profit topped estimates and it offered upbeat revenue guidance for 2024.

7 days ago - Market Watch

Bausch + Lomb Will Participate at the 2023 Wells Fargo Healthcare Conference

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman ...

6 months ago - Business Wire

Bausch Health's Bausch + Lomb to Acquire Novartis' XIIDRA(R)

LAVAL, QC / ACCESSWIRE / June 30, 2023 / Bausch + Lomb Corporation (NYSE/TSX:BLCO), a subsidiary of Bausch Health Companies Inc. (NYSE/TSX:BHC), announced that it has entered into a definitive agreeme...

Other symbols: BHCNVS
8 months ago - Accesswire

20 Stocks That Look Like They're in Bubble Territory Right Now

Stocks that are difficult to sell short are likely to be overvalued, a new study finds. These fit the bill.

9 months ago - Barrons

Bausch + Lomb and Heidelberg Engineering Announce the Introduction of SeeLuma™ Fully Digital Surgical Visualization Platform

VAUGHAN, Ontario & HEIDELBERG, Germany--(BUSINESS WIRE)--Bausch + Lomb, a leading global eye health company dedicated to helping people see better to live better, and Heidelberg Engineering, today ann...

11 months ago - Business Wire

Bausch + Lomb Appoints Bob Bailey as Executive Vice President and Chief Legal Officer and Andrew Stewart as President, Ophthalmic Pharmaceuticals

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live bet...

11 months ago - Business Wire

SparingVision appoints Joseph C. Papa as Chairman

SparingVision appoints Jo seph C. Papa as Chairman

Other symbols: NTLA
11 months ago - GlobeNewsWire

Bausch + Lomb beats Q4 profit and revenue estimates

Bausch + Lomb Corp. BLCO, -2.01% said Wednesday it had a loss of $1 million, or breakeven on a per-share basis, for the fourth quarter, after earnings of $51 million, or 15 cents a share, in the year-...

Other symbols: BHC
1 year ago - Market Watch

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2022 Results

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”, “we” or “our”), a leading global eye health company dedicated to helping people see be...

1 year ago - Business Wire

After IPO, Bausch + Lomb turns to an industry favorite to run the company

Bausch + Lomb Corp.'s decision to bring back Brent Saunders as CEO hints at the company's broader ambitions in the global eye-care market.

1 year ago - Market Watch

Bausch + Lomb names ex-CEO Brent Saunders as CEO, replacing Joseph Papa

Bausch + Lomb Corp. BLCO, +1.31% said Wednesday it has named Brent Saunders as chief executive and chair effective March 6. Saunders, who will return to the company he headed from 2010 to 2013, will r...

Other symbols: BHC
1 year ago - Market Watch

New Bausch + Lomb Social Media Campaign Highlights What ‘Sights' Inspire AMD Patients

Campaign to Feature Personal Stories and Images from Bausch + Lomb SightMatters Community Members During Age-Related Macular Degeneration Month

1 year ago - Business Wire

Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb's VISUDYNE® (Verteporfin for Injection)

VAUGHAN, Ontario & TAMPERE, Finland--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live...

Other symbols: BHC
1 year ago - Business Wire

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, will relea...

Other symbols: BHC
1 year ago - Business Wire

Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today anno...

1 year ago - Business Wire

Bausch + Lomb Publishes Update Presentation for the 41st Annual J.P. Morgan Healthcare Conference

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live ...

1 year ago - Business Wire

Bausch + Lomb Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today ann...

Other symbols: BHC
1 year ago - Business Wire

Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in Ophthalmology

VAUGHAN, Ontario & HEIDELBERG, Germany--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to l...

1 year ago - Business Wire

Bausch + Lomb and Glaucoma Research Foundation Announce Launch of Screen, Protect, Cure Campaign In Recognition of Glaucoma Awareness Month

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Glauco...

1 year ago - Business Wire

Bausch + Lomb Amends CEO Separation Agreement

VAUGHAN, ON , Dec. 22, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "Company"), a leading global eye health company dedicated to helping people see better to...

1 year ago - PRNewsWire

Bausch + Lomb Receives 510(k) Clearance from FDA for Biotrue® Hydration Boost Contact Lens Rehydrating Drops

Provides Lenses Up to Eight Hours of Moisture* VAUGHAN, ON , Dec. 13, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated t...

1 year ago - PRNewsWire

Bausch + Lomb's ONE by ONE and Biotrue® Eye Care Recycling Programs Win Gold for Most Environmentally Friendly Service of the Year from Best in Biz Awards

VAUGHAN, ON , Dec. 12, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, tod...

1 year ago - PRNewsWire

Bausch + Lomb's Biotrue® Hydration Plus Multi-Purpose Solution Receives Product of the Year Award from Business Intelligence Group's 2022 BIG Awards for Business

VAUGHAN, ON , Nov. 29, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, tod...

1 year ago - PRNewsWire

Bausch + Lomb Reports More Than 58 Million Units of Contact Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

VAUGHAN, ON , Nov. 15, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, tod...

1 year ago - PRNewsWire

Bausch + Lomb Announces Participation at the 5th Annual Evercore ISI HealthCONx Conference

VAUGHAN, ON , Nov. 7, 2022 /PRNewswire/ -- Bausch + Lomb Corporation, (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, tod...

1 year ago - PRNewsWire